Application
Immunoperoxidase staining of formalin-fixed, paraffin-embedded human breast carcinoma tissue showing membrane and cytoplasmic localization.
WB
(B) The expressions of p-JAK2 (Tyr1007), JAK2, p-STAT3 (Tyr705), STAT3 and CTSC in the liver were analyzed by western blot.
WB
(A) HepG2 cells treated with 10 μM TSN or 50 μM AG490 for 24 h were analyzed by western blot for the protein levels of p-JAK2 (Tyr1007), JAK2, p-STAT3 (Tyr705), STAT3 and CTSC.
WB
(A) HepG2 cells treated with RA (0, 5, 10, 20 μM) for 24 h were analyzed by western blot for the protein levels of p-JAK2 (Tyr1007), JAK2, p-STAT3 (Tyr705), STAT3 and CTSC. (B) HepG2 cells were treated with 10 μM TSN for 24 h after pretreatment with 20 μM RA or vehicle for 3 h. The expressions of p-JAK2 (Tyr1007), JAK2, p-STAT3 (Tyr705), STAT3 and CTSC were analyzed by western blot. HepG2 cells were treated by 10 μM TSN or 20 μM RA for 24 h with 20 μM RA pretreatment for 3 h.
WB
(A-B) The expression levels of p-JAK2 (Tyr1007), JAK2, p-STAT3 (Tyr705) and STAT3 were analyzed by Western blot.
WB
(B) The protein expressions of p-JAK2 (Tyr1007), JAK2, p-STAT3 (Tyr705), STAT3, LC3B and P62 were analyzed by Western blot.